Trade Mark Journal No.2025/037 12 September 2025

UK00004257357 1 September 2025 (9,42,44)

Sikila

International priority date claimed: 27 August 2025 (European Union Intellectual Property Office (EUIPO)) (019238295)

Class 9: Downloadable software in the nature of a mobile application for managing sickle cell disease, including health tracking, medication management, symptom logging, community-based support, AI-driven pain episode analysis, blood transfusion tracking, sleep monitoring, hydration intake tracking, medication adherence reminders; Downloadable mobile applications for health and wellness tracking, namely, logging and monitoring of symptoms, medication, pain, sleep, hydration, and blood transfusion data; downloadable mobile applications for generating medical reports, providing notifications, and supporting community engagement for individuals with chronic health conditions.
Class 42: Providing temporary use of on-line non-downloadable software for health tracking, AI-powered analysis of pain episodes, medication management, symptom logging, encrypted storage of medical data; Software as a service (SAAS) services featuring software for tracking sickle cell disease symptoms, monitoring hydration, monitoring sleep patterns, monitoring blood transfusions, community discussions with AI-assisted insights; Software as a Service (SaaS) featuring software for health data management, namely, storing, analysing, and sharing medical and wellness information; providing online non-downloadable software for generating automated health reports, trend analysis, and patient support tools; platform as a service (PaaS) featuring computer software platforms for integrating third- party health data applications and APIs.
Class 44: Providing online health information via a mobile application; providing health data analytics, namely, generating medical reports, identifying health patterns, and issuing health alerts for individuals living with chronic conditions.

Leuvon van der Leeuw

Representative: Regimark SIA